Wuxi, China

Zongyan Sha

This inventor holds 1 USPTO granted patent. Top assignee: Jiangnan University. Active years: 2021.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zongyan Sha: Innovator in Enzymatic Conversion

Introduction

Zongyan Sha is a notable inventor based in Wuxi, China. He has made significant contributions to the fields of gene engineering and enzyme engineering. His innovative work focuses on the enzymatic conversion processes that have practical applications in various industries.

Latest Patents

Zongyan Sha holds a patent for a method titled "Method for producing 9alpha-hydroxy androstane-4-alkene-3,17-diketone by enzymatic conversion." This patent describes a process that utilizes specific enzymatic reactions to produce 9-OH-AD efficiently. The method involves the expression of oxidation subunit KshA, reduction subunit KshB, and an unknown active subunit KshC sourced from a specific strain. Under optimal conditions, the process achieves a remarkable molar conversion rate of 96.7%, showcasing its efficiency and environmental benefits.

Career Highlights

Zongyan Sha is affiliated with Jiangnan University, where he conducts his research and development activities. His work has led to advancements in enzymatic processes that are both cost-effective and environmentally friendly. He has demonstrated a commitment to innovation in the field of biocatalysis.

Collaborations

Zongyan Sha has collaborated with notable colleagues, including Zhiming Rao and Xian Zhang. These partnerships have contributed to the success of his research endeavors and the development of his patented methods.

Conclusion

Zongyan Sha is a prominent inventor whose work in enzymatic conversion has the potential to impact various industries positively. His innovative methods reflect a dedication to efficiency and sustainability in scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…